Search results for "Dizziness"


 
Results 71 - 80 of about 115 for "Dizziness".
Sort by: Relevance | Newest | Oldest

First device approved to treat congenital heart disease

This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2021/05/first-device-approved-to-treat-congenital-heart-disease.htm
1 May 2021

Recommended: Move hydrocodone combo products to schedule II

This regulatory update covers a proposed reclassification of hydrocodone combination products from schedule III to schedule II, and approval of an extended-release version of hydrocodone bitartrate for pain management.
https://immattersacp.org/archives/2014/01/fda.htm
1 Jan 2014

First AI device approved to detect diabetic retinopathy

This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2018/06/first-ai-device-approved-to-detect-diabetic-retinopathy.htm
1 Jun 2018

Peanut butter recall issued, reminder for topical anesthetics

A summary of approvals, recalls, warnings and alerts.
https://immattersacp.org/archives/2009/03/fda.htm
1 Mar 2009

MKSAP Quiz: Progressive fatigue, dyspnea

A 28-year-old previously healthy woman is evaluated in the hospital for a 3-week history of progressive fatigue, dyspnea with exertion, and easy bruisability. Following a physical exam, lab studies, and peripheral blood smear, what is the most appropriate treatment?.
https://immattersacp.org/archives/2015/03/mksap.htm
1 Mar 2015

FDA releases action plan on artificial intelligence software

This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2021/03/fda-releases-action-plan-on-artificial-intelligence-software.htm
1 Mar 2021

FDA issues alert for CellCept, recalls for Solodyn, Digitek

An overview of agency actions, including an alert for CellCept and recalls for Solodyn and Digitek.
https://immattersacp.org/archives/2008/07/fda.htm
1 Jul 2008

Warnings on long-term dual antiplatelet therapy, more

This update covers the recall of rapid gram-negative combo panels, approval of an extended-release opioid analgesic, and a new rule about labeling prescription drugs related to pregnancy and lactation.
https://immattersacp.org/archives/2015/02/fda.htm
1 Feb 2015

Doripenem not for pneumonia; migraine device approved

This update covers a labeling change for doripenem (Doribax) and a warning about risk of death for ventilator patients with pneumonia, among other regulatory actions.
https://immattersacp.org/archives/2014/05/fda.htm
1 May 2014

New grass allergy treatment, opioid overdose solution

This update covers approval of an allergen extract to treat allergic rhinitis induced by grass pollen and of a handheld injector of naloxone for emergency treatment of known or suspected opioid overdose.
https://immattersacp.org/archives/2014/06/fda.htm
1 Jun 2014

Result Page: Prev   3   4   5   6   7   8   9   10   11   12   Next